Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Danno13on Mar 26, 2024 3:48pm
121 Views
Post# 35953831

RE:3 plus

RE:3 plus Try $7.39 back in 2019 that's the high Medipharm hit.Your right were a better company now by far.I think eventually we will hit higher then $7.39 because were with a bigger market.We have 401 million outstanding for 2024 .   As of May 2019MediPharm Labs Corp had approximately 105.32 million shares outstanding.                                                                                                Revenue for 2014 is estimated at $42.11 million.                                                                                                       In 2019MediPharm Labs Corp reported a total revenue of $129 millionAdditionally, their fourth-quarter revenue for the same year was $32 million1. It’s impressive to see their growth and profitability during that period! I think in a year we can beat 2019's  REVENUES I think tomorrow they will report revenue greater then 10 million for the quarter    
<< Previous
Bullboard Posts
Next >>